What is the appropriate treatment for incontinence-associated dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Incontinence-Associated Dermatitis

The primary treatment of incontinence-associated dermatitis involves reducing skin exposure to urine and stool through high-absorbency incontinence products with regular changes, combined with protective skin care products, mild cleansing, and topical antibiotics/antifungals for infected or weeping lesions 1, 2.

Core Treatment Algorithm

Step 1: Address the Underlying Incontinence

  • Assess the type and severity of incontinence first
  • Implement continence enhancement strategies where possible
  • Use high-absorbency incontinence products and change them regularly to prevent epidermal overhydration 1

Step 2: Skin Protection and Cleansing

  • Apply protective skin care products as a barrier
  • Use mild cleansing agents only—avoid harsh soaps and detergents that damage the skin barrier 3
  • Replace standard soaps with emollients, as soaps are irritants that compound dermatitis even when not the primary cause 3

Step 3: Treat Active Dermatitis Based on Severity

For weeping erosions, excoriations, or infected IAD:

  • Apply topical antibiotics (such as Biomycin) combined with antifungal medication (clotrimazole) 2
  • This combination showed 61% complete healing and 22% >50% improvement in a 76-patient study, with mean treatment duration of 10.3 days 2
  • This approach is particularly effective for grade 2 IAD with secondary infection

For persistent dermatitis without infection:

  • Topical corticosteroids for short-term, controlled use in severe cases 1
  • Topical tacrolimus is supported for contact dermatitis management 3

Step 4: Consider Advanced Measures for Severe Cases

  • External urine or stool collection devices
  • Indwelling urinary catheters (only in severe, refractory cases) 1

Critical Differential Diagnosis

IAD is an irritant contact dermatitis, but allergic contact dermatitis is the most common differential diagnosis in older adults 1. The distinction is essential because management differs—allergic contact dermatitis requires allergen identification and avoidance, while IAD requires moisture management.

Common Pitfalls to Avoid

  • Do not use harsh cleansers or soaps: These contain emulsifiers/surfactants that significantly damage the skin barrier, especially in predisposed individuals 3
  • Do not delay treatment of secondary infection: Weeping erosions and excoriations require prompt topical antimicrobial therapy 1, 2
  • Do not overlook the need for regular product changes: Even high-absorbency products must be changed frequently to prevent prolonged skin exposure 1

Evidence Quality Considerations

The most recent comprehensive review 1 from 2025 provides the clearest treatment framework for IAD specifically in older adults. The 2021 retrospective study 2 offers the strongest evidence for topical antibiotic/antifungal combination therapy with concrete outcome data (76 patients, 83% showing ≥50% improvement). While the British Association of Dermatologists guidelines 3 are authoritative for contact dermatitis broadly, they focus on allergic and occupational contact dermatitis rather than IAD specifically, though their principles regarding barrier protection and avoiding harsh cleansers remain directly applicable.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.